首页> 外文期刊>International ophthalmology >Analysis of the visual and refractive outcome following laser in situ keratomileusis (LASIK) retreatment over a four-year follow-up period.
【24h】

Analysis of the visual and refractive outcome following laser in situ keratomileusis (LASIK) retreatment over a four-year follow-up period.

机译:在四年的随访期内,对激光原位角膜磨镶术(LASIK)进行再治疗后的视觉和屈光结果进行了分析。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the safety and refractive stability following LASIK retreatment over a four-year follow-up period. METHODS: In this retrospective study, 60 eyes of 52 patients underwent LASIK retreatment for residual refractive errors after LASIK. Retreatment was performed by lifting the original flap followed by laser ablation of the stromal bed. The main outcome measures at the latest follow-up visit were efficacy, predictability, safety and stability. The mean follow-up time after retreatment was 22.3 +/- 10.5 (range 12-48 months). RESULTS: The baseline mean spherical equivalent (SE) was -4.85 +/- 2.57 dioptres (D) (range +2.25 to -11.75 D). At the latest follow-up visit, the uncorrected visual acuity (UCVA) was 6/9 or better in 88% of the eyes, the mean SE was -0.33 +/- 0.8 D (-2.50 to +2.25 D), and 77% of the eyes were within +/-0.50 D of target refraction. None of the patients lost lines of best corrected visual acuity (BCVA) and 25 eyes (41%) gained one or more lines. Three eyes (5%) developed peripheral epithelial in-growth and none of the patients had corneal ectasias or retinal complications. CONCLUSION: LASIK retreatment is a safe and effective procedure for correcting residual refractive errors after LASIK. After retreatment, the visual and refractive outcome remained stable during the four-year follow-up period of the study.
机译:目的:在四年的随访期内评估LASIK手术后的安全性和屈光稳定性。方法:在这项回顾性研究中,对52例患者中的60眼进行了LASIK复治,以治疗LASIK后残留的屈光不正。通过抬起原始皮瓣,然后激光消融基质床进行再治疗。最近一次随访的主要结果指标是疗效,可预测性,安全性和稳定性。再治疗后的平均随访时间为22.3 +/- 10.5(范围12-48个月)。结果:基线平均球当量(SE)为-4.85 +/- 2.57屈光度(D)(范围+2.25至-11.75 D)。在最近的随访中,88%的眼睛的未矫正视力(UCVA)为6/9或更好,平均SE为-0.33 +/- 0.8 D(-2.50至+2.25 D)和77 %的眼睛在目标屈光度的+/- 0.50 D之内。没有患者失去最佳矫正视力(BCVA)系,有25眼(41%)获得了一个或多个系。三只眼(5%)出现周围上皮向内生长,所有患者均未发生角膜扩张或视网膜并发症。结论:LASIK复治术是纠正LASIK术后残余屈光不正的安全有效方法。重新治疗后,在研究的四年随访期内,视觉和屈光结局保持稳定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号